SeraGene Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
17
SeraGene Therapeutics General Information
Description
Developer of ribonucleic acid-based therapeutics designed to provide long-lasting control over coagulation disorders. The company offers liver-targeted RNA agents, nanomedicine delivery systems, and a diversified preclinical pipeline, enabling healthcare providers to manage bleeding and thrombotic conditions with reduced treatment burden and improved safety for underserved patient populations.
Contact Information
Website
www.seragenetx.comCorporate Office
- 2405 Wesbrook Mall
- 4th floor
- Vancouver, British Columbia V6T 1Z3
- Canada
Corporate Office
- 2405 Wesbrook Mall
- 4th floor
- Vancouver, British Columbia V6T 1Z3
- Canada
SeraGene Therapeutics Timeline
SeraGene Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Accelerator/Incubator | 01-Jan-2026 | Completed | Pre-Clinical Trials | |||
| 10. Early Stage VC | 20-Nov-2025 | Completed | Pre-Clinical Trials | |||
| 9. Seed Round | Completed | Pre-Clinical Trials | ||||
| 8. Accelerator/Incubator | 20-Aug-2025 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 24-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 05-Dec-2024 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 24-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SeraGene Therapeutics Signals
SeraGene Therapeutics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| WBL Fellows Program | Accelerator/Incubator | |||
| Pathway to Cures | Not-For-Profit Venture Capital | Minority | ||
| Life Sciences BC | Accelerator/Incubator | |||
| HATCH Venture Builder | Accelerator/Incubator | |||
| adMare Bioinnovations | Corporation |
SeraGene Therapeutics FAQs
-
When was SeraGene Therapeutics founded?
SeraGene Therapeutics was founded in 2022.
-
Where is SeraGene Therapeutics headquartered?
SeraGene Therapeutics is headquartered in Vancouver, Canada.
-
What is the size of SeraGene Therapeutics?
SeraGene Therapeutics has 7 total employees.
-
What industry is SeraGene Therapeutics in?
SeraGene Therapeutics’s primary industry is Biotechnology.
-
Is SeraGene Therapeutics a private or public company?
SeraGene Therapeutics is a Private company.
-
What is SeraGene Therapeutics’s current revenue?
The current revenue for SeraGene Therapeutics is .
-
How much funding has SeraGene Therapeutics raised over time?
SeraGene Therapeutics has raised $3K.
-
Who are SeraGene Therapeutics’s investors?
WBL Fellows Program, Pathway to Cures, Life Sciences BC, HATCH Venture Builder, and adMare Bioinnovations are 5 of 17 investors who have invested in SeraGene Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process